Education Library

William O’Neill, MD, presents data supporting multivessel intervention with Impella® support in patients with AMI cardiogenic shock. 

Benham Tehrani, MD explains how to understand Impella waveforms, assess Impella position, and best practices for repositioning Impella in part 2 of this 6-video series.

Dr. Andreas Schäfer shares insights that may pertain to COVID-19 gained from mechanical circulatory support in refractory cardiogenic shock due to influenza virus-related myocarditis.

Navin Kapur, MD, discusses the incidence and clinical outcomes of stroke in ST-elevation myocardial infarction (STEMI) and cardiogenic shock.

Benham Tehrani, MD describes initial management tips for patients supported with the Impella heart pump and provides an overview for this 6-video series.

Elazer Edelman, MD, PhD discusses how achieving optimal therapeutic benefit in patients with cardiogenic shock requires metrics to guide titration and weaning of support. 

Take a look at the cardiogenic shock program with Benham Tehrani, MD, Alexander Truesdell, MD, Carolyn Rosner, NP, Shashank Sinha, MD, and Chuck Murphy, MD.

Jo Kajewski, Advanced Impella® Trainer, answers some frequently asked questions about LV metrics displayed using Impella SmartAssist® technology.

Jessica Page, Global Impella Trainer, reviews the clinical signs and symptoms of hemolysis and provides tips for reducing the risk of hemolysis in patients supported with the Impella heart pump.

Jessica Page, Advanced Impella® Trainer, reviews how to use the SmartAssist trend screen during weaning of Impella.

To the surprise of all the treating cardiologists, the patient presented with an ejection fraction of 5%, which improved to 55% on Day 6 after support with Impella RP® and Impella CP®.